A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

Satish Keshav, Tomáš Vaňásek, Yaron Niv, Robert Petryka, Stephanie Howaldt, Mauro Bafutto, István Rácz, David Hetzel, Ole Haagen Nielsen, Séverine Vermeire, Walter Reinisch, Per Karlén, Stefan Schreiber, Thomas J Schall, Pirow Bekker

Research output: Contribution to journalJournal articleResearchpeer-review

130 Citations (Scopus)
Original languageEnglish
Article numbere60094
JournalP L o S One
Volume8
Issue number3
Number of pages12
ISSN1932-6203
DOIs
Publication statusPublished - 2013

Cite this